These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19033198)

  • 1. Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.
    Li Z; Boone D; Hann SR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18794-9. PubMed ID: 19033198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Myc-nucleophosmin-ARF network: a complex web unveiled.
    Li Z; Hann SR
    Cell Cycle; 2009 Sep; 8(17):2703-7. PubMed ID: 19652540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.
    Li Z; Hann SR
    Oncogene; 2013 Apr; 32(15):1988-94. PubMed ID: 22665062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nucleolar Protein GLTSCR2 Is an Upstream Negative Regulator of the Oncogenic Nucleophosmin-MYC Axis.
    Kim JY; Cho YE; Park JH
    Am J Pathol; 2015 Jul; 185(7):2061-8. PubMed ID: 25956029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.
    Boone DN; Qi Y; Li Z; Hann SR
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):632-7. PubMed ID: 21187408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
    Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD
    Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
    Li J; Sejas DP; Burma S; Chen DJ; Pang Q
    Carcinogenesis; 2007 Jun; 28(6):1163-70. PubMed ID: 17277230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency.
    Zwolinska AK; Heagle Whiting A; Beekman C; Sedivy JM; Marine JC
    Oncogene; 2012 Jul; 31(28):3311-21. PubMed ID: 22081066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Playing both sides: nucleophosmin between tumor suppression and oncogenesis.
    Di Fiore PP
    J Cell Biol; 2008 Jul; 182(1):7-9. PubMed ID: 18625839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and functional interaction of the TPL2 kinase with nucleophosmin.
    Kanellis DC; Bursac S; Tsichlis PN; Volarevic S; Eliopoulos AG
    Oncogene; 2015 May; 34(19):2516-26. PubMed ID: 24998852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p19ARF directly and differentially controls the functions of c-Myc independently of p53.
    Qi Y; Gregory MA; Li Z; Brousal JP; West K; Hann SR
    Nature; 2004 Oct; 431(7009):712-7. PubMed ID: 15361884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic localization of Mdm2 in cells expressing mutated NPM is mediated by p53.
    Strachotová D; Holoubek A; Wolfová K; Brodská B; Heřman P
    FEBS J; 2023 Sep; 290(17):4281-4299. PubMed ID: 37119456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis.
    Liu S; Tackmann NR; Yang J; Zhang Y
    Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
    Chen D; Shan J; Zhu WG; Qin J; Gu W
    Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation.
    Brough DE; Hofmann TJ; Ellwood KB; Townley RA; Cole MD
    Mol Cell Biol; 1995 Mar; 15(3):1536-44. PubMed ID: 7862146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.